Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05724784 · ClinicalTrials.gov registry record · NA
Development and Feasibility Testing of a Suicide Prevention Intervention for Sexual and Gender Minority Youth
A NA study of Suicidal Ideation and Psychological Distress, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT05724784: Completed NA study of Suicidal Ideation and Psychological Distress, sponsored by University of Pittsburgh.
NCT05724784 is a NA study of Suicidal Ideation and Psychological Distress that has completed, run by University of Pittsburgh. The registered enrollment target is 11 participants, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05724784, a NA study of Suicidal Ideation and Psychological Distress, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to develop and test a brief, digital, suicide prevention intervention for sexual and gender minority (SGM) youth who have experienced cyberbullying. Leading up to this phase, the study team completed two prior study aims, focused on identifying perspectives of SGM youth's regarding their experiences with cyberbullying and priorities for an intervention, and a phase in which SGM youth codesigned the study's intervention with the study team. This resulted in the development of study's intervention, Flourish, which leverages a text messaging-based chatbot to reduce suicide risk following cyberbullying among SGM youth through improving distress tolerance, motivation for help-seeking, and social problem-solving. Current Study Aim: Conduct an open trial to assess the feasibility and acceptability of Flourish among cyberbullied SGM youth, ages 12-17 (N=10). Hypotheses: Feasibility will be evidenced by recruitment/retention rates \> 80% and use of Flourish among \> 70% of SGM youth. At follow-up, adolescents will report improved problem-solving capacity, distress tolerance, and motivation for help-seeking and reduced psychological distress and suicidal ideation compared to baseline.
Primary Outcome
Feasibility will be measured through recruitment rates of eligible participants, using a cut-off score of 80% for desirable recruitment rates.
Conditions Studied
Interventions
- BEHAVIORAL Flourish
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-05-24 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT05724784 record still lists
NCT05724784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Flourish is the first listed.
NCT05724784 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05724784 about?
NCT05724784 is a clinical study titled "Development and Feasibility Testing of a Suicide Prevention Intervention for Sexual and Gender Minority Youth". This study aims to develop and test a brief, digital, suicide prevention intervention for sexual and gender minority (SGM) youth who have experienced cyberbullying. Leading up to this phase, the study team completed two prior study aims, focused on identifying perspectives of SGM youth's regarding t...
What is the current status of trial NCT05724784?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2023-05-24. Estimated completion is 2024-09-30.
What conditions does trial NCT05724784 study?
This clinical trial studies the following conditions: Suicidal Ideation, Psychological Distress.
What interventions are being tested in trial NCT05724784?
The interventions under investigation include: Flourish (BEHAVIORAL).
Who is sponsoring clinical trial NCT05724784?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05724784 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05724784's enrollment target sits among peer trials
11 82nd of 84 higher than 3 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI